Filter results
You can narrow down the results using the filters
Topics
Our work
Diseases
11455 results
-
Implementation Plan for the National Palliative Care Strategy 2018
Our Implementation Plan for the National Palliative Care Strategy will help us improve palliative care services for all Australians. -
National Consultation of the Australian Medical Research and Innovation Priorities 2020-2022
AMRAB National Consultation of the Australian Medical Research and Innovation Priorities 2020-2022 presentation. -
Coronavirus (COVID-19) at a glance – 19 October 2020
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 19 October 2020. -
NMHWS taskforce meeting communique – 9 October 2020
This communique summarises the 10th meeting of the National Mental Health Workforce Strategy taskforce (NMHWS) held by video conference on 9 October 2020. -
Coronavirus (COVID-19) at a glance – 18 October 2020
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 18 October 2020. -
Coronavirus (COVID-19) at a glance – 17 October 2020
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 17 October 2020. -
Coronavirus (COVID-19) common operating picture – 15 October 2020
This infographic provides a weekly traffic light report of the coronavirus (COVID-19) situation across Australia issued on 15 October 2020. -
Government Response to the Review of the Transition Care Programme (TCP)
The Australian Government Response to the Transition Care Programme (TCP) Review’s Recommendations. -
COVID-19 outbreaks in Australian residential aged care facilities – 16 October 2020
This weekly report provides a snapshot of data on the impact of COVID-19 in residential aged care facilities nationally. The report includes data on the number of services impacted and number of staff and resident cases, as well as workforce, testing and PPE provided to affected services. -
Coronavirus (COVID-19) at a glance – 16 October 2020
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 16 October 2020. -
Tool to calculate and display polio risk assessment results
This Microsoft Excel-based tool allows automated calculation and display of risk assessment results as a semi-quantitative risk characterisation estimate. -
Coronavirus (COVID-19) at a glance – 15 October 2020
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 15 October 2020. -
Debilitating symptom complexes attributed to ticks (DSCATT) clinical pathway
This document supports clinicians to make diagnoses and referrals for patients presenting with chronic symptoms attributed to an unknown illness. -
Aboriginal and Torres Strait Islander Advisory Group on COVID-19 communique – 15 October 2020
This communique summarises the meeting of the Aboriginal and Torres Strait Islander Advisory Group on COVID-19 held on 15 October 2020. -
Life Saving Drugs Program resources – Mucopolysaccharidosis type I (MPS I)
A collection of resources for health professionals to help people with mucopolysaccharidosis type I (MPS I) access laronidase (Aldurazyme®) under the Life Saving Drugs Program. -
Life Saving Drugs Program resources – Mucopolysaccharidosis type II (MPS II)
A collection of resources for health professionals to help people with mucopolysaccharidosis type II (MPS II) access idursulfase (Elaprase®) under the Life Saving Drugs Program. -
Life Saving Drugs Program resources – Mucopolysaccharidosis type IVA (MPS IVA)
A collection of resources for health professionals to help people with mucopolysaccharidosis type IVA (MPS IVA) access elosulfase alfa (Vimizim®) under the Life Saving Drugs Program. -
Life Saving Drugs Program resources – Mucopolysaccharidosis type VI (MPS VI)
A collection of resources for health professionals to help people with mucopolysaccharidosis type VI (MPS VI) access galsulfase (Naglazyme®) under the Life Saving Drugs Program (LSDP). -
Life Saving Drugs Program resources – Pompe disease
A collection of resources for health professionals to help people with Pompe disease access alglucosidase alfa (Myozyme®) and avalglucosidase alfa (Nexviazyme®) under the Life Saving Drugs Program. -
Life Saving Drugs Program resources – Hereditary tyrosinaemia type 1
A collection of resources for health professionals to help people with hereditary tyrosinaemia type 1 access nitisinone (Orfadin® and Nityr™) under the Life Saving Drugs Program. -
Life Saving Drugs Program resources – Late-Infantile onset batten disease (CLN2 disease)
A collection of resources for health professionals to help people with CLN2 disease access cerliponase alfa (Brineura®) under the Life Saving Drugs Program. -
Coronavirus (COVID-19) at a glance – 14 October 2020
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 14 October 2020. -
Support for Australia’s thalidomide survivors
Australian Government response to the Senate Community Affairs References Committee inquiry into support for Australia’s thalidomide survivors -
Coronavirus (COVID-19) at a glance – 13 October 2020
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 13 October 2020. -
Post-market validation of a further two serological assays for COVID-19 – updated report
This report present results of post-market validation of a further 2 serological assays for the detection of SARS-CoV-2 antibodies.